Hubei Biocause Pharmaceutical (000627) — Cash Flow Quality Index
Hubei Biocause Pharmaceutical (000627) has a Cash Flow Quality Index of 135.70x as of March 2023. Operating cash flow of CN¥6.13 Billion exceeds net income of CN¥45.21 Million, indicating high earnings quality where cash backs reported profits. Explore investment intensity of Hubei Biocause Pharmaceutical to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Hubei Biocause Pharmaceutical Cash Flow Quality Index (2001–2022)
Historical Cash Flow Quality Index for Hubei Biocause Pharmaceutical across 15 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check Hubei Biocause Pharmaceutical (000627) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Hubei Biocause Pharmaceutical (2001–2022)
Year-by-year earnings quality comparison for Hubei Biocause Pharmaceutical. For live market cap and the full company financial profile, see Hubei Biocause Pharmaceutical (000627) market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | 27.46x | CN¥7.52 Billion | CN¥274.05 Million | ▲ +209.7% |
| 2021 | 8.86x | CN¥4.17 Billion | CN¥470.71 Million | ▼ -76.0% |
| 2020 | 36.91x | CN¥21.42 Billion | CN¥580.29 Million | ▲ +129.2% |
| 2019 | 16.10x | CN¥28.60 Billion | CN¥1.78 Billion | ▲ +42.6% |
| 2018 | 11.29x | CN¥14.98 Billion | CN¥1.33 Billion | ▲ +3370.4% |
| 2017 | 0.33x | CN¥431.58 Million | CN¥1.33 Billion | ▲ +124.7% |
| 2016 | -1.32x | CN¥-2.34 Billion | CN¥1.78 Billion | ▼ -596.8% |
| 2015 | -0.19x | CN¥-46.73 Million | CN¥247.27 Million | ▼ -102.4% |
| 2012 | 7.93x | CN¥93.79 Million | CN¥11.82 Million | ▲ +0.0% |
| 2010 | 7.93x | CN¥224.58 Million | CN¥28.32 Million | ▲ +569.2% |
| 2007 | 1.19x | CN¥118.56 Million | CN¥100.05 Million | ▼ -55.3% |
| 2006 | 2.65x | CN¥128.19 Million | CN¥48.37 Million | ▼ -61.3% |
| 2005 | 6.85x | CN¥48.66 Million | CN¥7.10 Million | ▼ -37.8% |
| 2004 | 11.01x | CN¥56.07 Million | CN¥5.09 Million | ▲ +999.2% |
| 2001 | 1.00x | CN¥37.30 Million | CN¥37.23 Million | — |